| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
parkin RBR E3 ubiquitin protein ligase | 0.431 | 0.846 | 6.9E-07 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2010 | 2014 | ||||||||
|
NADPH oxidase 4 | 0.471 | 0.885 | 5.8E-20 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 2011 | 2014 | ||||||||
|
RELA proto-oncogene, NF-kB subunit | 0.406 | 0.885 | 1.00 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 2004 | 2020 | ||||||||
|
replication factor C subunit 1 | 0.541 | 0.808 | 0.97 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
tRNA methyltransferase 11 homolog | 0.729 | 0.269 | 3.9E-12 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
S100 calcium binding protein A4 | 0.448 | 0.769 | 6.2E-03 |
|
disease | 0.380 | None | 1.000 | 1 | 0 | 2006 | 2018 | ||||||||
|
oxytocin/neurophysin I prepropeptide | 0.615 | 0.423 | 0.71 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
Y-box binding protein 1 | 0.519 | 0.769 | 0.95 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 2015 | 2017 | ||||||||
|
actin alpha 2, smooth muscle | 0.508 | 0.846 | 0.93 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1997 | 2019 | ||||||||
|
mitogen-activated protein kinase kinase 6 | 0.631 | 0.615 | 0.91 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2004 | 2014 | ||||||||
|
ras homolog family member J | 0.686 | 0.308 | 6.4E-03 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
disease | 0.600 | None | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
DNA polymerase beta | 0.606 | 0.654 | 3.4E-05 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 2002 | 2014 | ||||||||
|
ATPase copper transporting alpha | 0.494 | 0.769 | 1.00 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
NDRG family member 2 | 0.518 | 0.692 | 2.2E-05 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 2004 | 2014 | ||||||||
|
serpin family B member 5 | 0.582 | 0.577 | 3.6E-03 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2004 | 2014 | ||||||||
|
Purkinje cell protein 4 | 0.682 | 0.423 | 2.2E-03 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
lymphoid enhancer binding factor 1 | 0.486 | 0.769 | 1.00 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1997 | 2019 | ||||||||
|
ornithine decarboxylase 1 | 0.510 | 0.731 | 0.17 |
|
disease | 0.390 | None | 1.000 | 1 | 0 | 1987 | 2018 | ||||||||
|
BCL2 antagonist/killer 1 | 0.555 | 0.769 | 7.4E-06 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
S100 calcium binding protein A9 | 0.433 | 0.885 | 0.48 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 2004 | 2019 | ||||||||
|
C-C motif chemokine ligand 20 | 0.474 | 0.846 | 2.4E-04 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
solute carrier family 2 member 1 | 0.388 | 0.808 | 0.99 |
|
disease | 0.380 | None | 1.000 | 1 | 0 | 1996 | 2020 | ||||||||
|
calcium voltage-gated channel auxiliary subunit alpha2delta 1 | 0.641 | 0.500 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2004 | 2004 |